Advertisement

Topics

karo bio Company Profile

05:28 EDT 20th September 2017 | BioPortfolio

KARO BIO IS AN ESTABLISHED GLOBAL LEADER IN THE FIELD OF NUCLEAR RECEPTOR RESEARCH AND DRUG DISCOVERY.

Karo Bio is committed to finding new and better pharmaceuticals that can effectively treat serious diseases without the deleterious side effects commonly experienced with today's drugs.



Karo Bio is a drug discovery company focusing its research on the discovery and pre-clinical phases of drug development. Research is conducted primarily in the area of nuclear receptors.



Nuclear receptors are proteins in the cell nucleus that act as receivers for a number of key hormones that enable the essential regulation of organs in the body. Through the understanding of nuclear receptors in drug design, new tissue selective drugs can be developed that have fewer or no side effects.



Through ongoing partnerships with outstanding academic and research institutions, such as the Karolinska Institute, home of the Nobel Prize, Karo Bio continues to be at the forefront of new discoveries to advance the Company's work with nuclear receptors and other research endeavors. With the current programs underway, Karo Bio is diligently working to discover and develop drugs for important therapeutic areas such as women's health, diabetes, inflammatory disease, obesity, cardiovascular disease, and atherosclerosis.



In addition to nuclear receptor research and development, Karo Bio also offers a novel approach to target validation and high-throughput screening with proprietary BioKey® technology. This proteomics-based drug discovery technology is ideal for the development of screens for targets of unknown function and for targets difficult to screen by traditional methods. The proprietary BioKey® technology is used for internal discovery programs and collaborative out-licensing agreements with pharmaceutical and biotechnology companies.

Location

Novum 141 57
Huddinge
Huddinge
141 57
Sweden

Contact

Phone: ++46 8 608 6074
Fax: ++46 774 8261
Email: bo.carlsson@karobio.se


News Articles [10 Associated News Articles listed on BioPortfolio]

Nasdaq Stockholm AB: Handelsstopp i/Trading halt in Karo Pharma AB (102/17)

Nasdaq Stockholm AB har fattat beslut om att stoppa handeln för aktierna i Karo Pharma AB (KARO, ISIN-kod SE0007464888, orderbok ID 003927 från klockan 12:45 tills vidare med hänvisning till 22 kap...

Nasdaq Stockholm AB: Upphävt handelsstopp i/Resumed trading in Karo Pharma AB (103/17)

Med hänvisning till pressmeddelandet som Karo Pharma AB publicerade i dag klockan 15:10 har Nasdaq Stockholm AB i samråd med Finansinspektionen beslutat att handeln i aktierna i Karo Pharma AB (KAR....

NASDAQ OMX Nordic: Derivatives: Adjustment due to extraordinary dividend in Karo Pharma (16/17)

The Annual General Meeting (AGM) of Karo Pharma AB (Karo Pharma) held on May 11, 2017 approved an extraordinary dividend of SEK 0.22 per share in addition to the ordinary dividend of SEK 0.28 per s...

Weifa ASA: Weifa ASA: Karo Pharma commences voluntary cash offer to acquire the entire issued share capital of Weifa

Weifa ASA ("Weifa"; OSE: WEIFA) today announced that Karo Pharma AB (publ) ("Karo Pharma"), has commenced the voluntary cash offer (the "Offer") to acquire the entire issued share capital of Weifa...

Weifa ASA: Weifa ASA: Karo Pharma AB announces a recommended voluntary cash offer to acquire all shares in Weifa ASA

Karo Pharma AB announces a recommended voluntary cash offer to acquire all shares in Weifa ASA · Cash offer at NOK 35 per Weifa share valuing the total share capital of Weifa at approximately NOK ...

XFRA KA6N: AUSSETZUNG/SUSPENSION

DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT: THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT: INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL KARO PHARMA ...

Karo Pharma AB KARO Financial and Strategic SWOT Analysis Review [Report Updated: 22062017] Prices from USD $125

Karo Pharma AB KARO Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalDat...

Karo Pharma AB KARO Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27072017] Prices from USD $250

SummaryKaro Pharma AB Karo Pharma, formerly Karo Bio AB, is a health care company that focuses on research and development of pharmaceutical products in the areas of cancer and autoimmune diseases. It...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

karo bio

KARO BIO IS AN ESTABLISHED GLOBAL LEADER IN THE FIELD OF NUCLEAR RECEPTOR RESEARCH AND DRUG DISCOVERY.Karo Bio is committed to finding new and better pharmaceuticals that can effectively treat serious...

Karo Bio AB

Karo Bio is an innovative drug discovery and development company specializing in nuclear receptors for the development of novel pharmaceuticals. The company has a strong project portfolio primarily ta...

More Information about "karo bio" on BioPortfolio

We have published hundreds of karo bio news stories on BioPortfolio along with dozens of karo bio Clinical Trials and PubMed Articles about karo bio for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of karo bio Companies in our database. You can also find out about relevant karo bio Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record